Posted by SLS on April 9, 2021, at 13:04:03
In reply to Re: New SNRI approved for ADHD: Viloxazine, posted by rjlockhart37 on April 9, 2021, at 12:03:10
Viloxazine has been around for awhile and had previous been characterized as a selective NE reuptake inhibitor. The discovery of serotonergic modulation is a new finding.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473988/
Linkadge - Do you have any thoughts as to why modulation 5-HT activity would help treat ADHD? Is it possible that the 5-HT effects don't contribute to its clinical effect in ADHD? I have done no reading about this.
Europe has always been more creative and liberal with its psychotropic drugh.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.The only thing necessary for the triumph of evil is that good men do nothing.
poster:SLS
thread:1114436
URL: http://www.dr-bob.org/babble/20210120/msgs/1114480.html